Join
Live feed
·
INSIDERFilingvia Quantisnow
PharmaCyte Biotech Inc. logo

Director Schechter Jonathan bought $48,232 worth of shares (60,000 units at $0.80), increasing direct ownership by 45% to 192,500 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PMCB· PharmaCyte Biotech Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PMCB (PharmaCyte Biotech Inc.) and more on Quantisnow.